Emmaus Life Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Emmaus Life Sciences generated cash of -$1,254,000, which is more than the previous year. Cash used in financing activities reached the amount of $7,411,000 last year. Net change in cash is therefore -$208,000.
Cash Flow
| 2012 | -2.63M | -25.5K | 2.59M |
|---|---|---|---|
| 2013 | -3.03M | 1.4K | 4.32M |
| 2014 | -3.27M | 0 | 3.33M |
| 2015 | -2.11M | 1.5K | 1.34M |
| 2016 | -2.97M | -82.3K | 2.94M |
| 2017 | -4.79M | -479.5K | 10.40M |
| 2018 | -9.03M | -361.8K | 7.20M |
| 2019 | -4.52M | -1.48M | 3.88M |
| 2020 | -2.45M | 5.47M | -2.31M |
| 2021 | -1.25M | -6.37M | 7.41M |
EMMAW Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.48M | 1.76M | 3.90M | 5.44M | 318.2K | 432.1K | 1.24M | 1.27M | 7.7K | 73.6K |
Operating activities | ||||||||||
Net income | -15.94M | 1.1M | -54.84M | -9.59M | -7.11M | -5.94M | -3.37M | -2.66M | -10.90M | -3.40M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 59K | 60K | 73K | 117.9K | 48.7K | 7.2K | 7.6K | 10.3K | 13K | 18.8K |
Stock-based compensation expense | 553K | 739K | 3.80M | 1.58M | 2.08M | 758.4K | 241.7K | 1.00M | 1.25M | 1.35M |
| Deferred income tax benefit | 553K | 739K | 3.80M | 1.58M | 2.08M | 758.4K | 241.7K | 1.00M | 1.25M | 1.35M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -845K | 1.95M | -361K | -500 | -1.4K | 6.7K | -2.5K | 17.3K | -14.2K | 6.8K |
Inventories | 2.22M | -245K | -3.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -1.25M | -2.45M | -4.52M | -9.03M | -4.79M | -2.97M | -2.11M | -3.27M | -3.03M | -2.63M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -190K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1K | -26.17M | -60K | -55.2K | -130K | -82.3K | 0 | 0 | 0 | -4.3K |
Acquisitions Net | 0 | 0 | -1.64M | -306.6K | -190K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -6.37M | 5.47M | -1.48M | -361.8K | -479.5K | -82.3K | 1.5K | 0 | 1.4K | -25.5K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 142K | 8.58M | 930.43K | 10.46M | 0 | 0 | 1.69M | 2.95M | 900 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -21K | -5.21M | 0 | -75.8K | 0 | -3.2K | 0 | -7.2K | -4.7K | -6.1K |
Cash used in financing activities | 7.41M | -2.31M | 3.88M | 7.20M | 10.40M | 2.94M | 1.34M | 3.33M | 4.32M | 2.59M |
Net Change In Cash | -208K | 718K | -2.13M | -2.19M | 5.13M | -113.9K | -808.5K | -33K | 1.26M | -65.9K |
Cash at end of period | 2.27M | 2.48M | 1.76M | 3.25M | 5.44M | 318.2K | 432.1K | 1.24M | 1.27M | 7.7K |
| Data source | Data source |